Biologics and Biosimilars

By Kate Greenwood
In Biologics and Biosimilars
Nov 17th, 2014
0 Comments
By Jordan Paradise The Biosimilars Price Competition and Innovation Act of 2009 (BPCIA) introduced a long-awaited, and highly-supported, abbreviated route to market for “biosimilar” and “interchangeable” biologic products. The goal was to create incentives for development and reduce health care costs in the same way that previous legislation had accomplished in the gen...